key: cord-0780533-2jktzqm2
authors: Rasmussen, Peter Vibe; Blanche, Paul; Strange, Jarl Emanuel; Butt, Jawad Haider; Dalgaard, Frederik; Kragholm, Kristian; Phelps, Matthew; Gislason, Gunnar; Hansen, Morten Lock
title: Thromboembolic events related to atrial fibrillation during the COVID-19 epidemic in Denmark
date: 2020-07-31
journal: Thromb Res
DOI: 10.1016/j.thromres.2020.07.048
sha: d827dfd0c46c640ef5160b1e3da54f08d825952d
doc_id: 780533
cord_uid: 2jktzqm2

nan

J o u r n a l P r e -p r o o f 2 The COVID-19 epidemic has threatened to overwhelm the health-care systems of European countries resulting in government decisions of extensive societal lockdowns. There has been considerable concerns regarding the collateral effects of the COVID-19 epidemic overshadowing the care of patients with other medical conditions including cardiovascular diseases. Of interest, decreases in the registered incidences of atrial fibrillation (AF) and ischemic stroke have been reported. 1,2 AF is a common reason for physician contact and AF patients are often recommended treatment with oral anticoagulants to mitigate the associated risk of thromboembolic events (TE).

Due to the COVID-19 crisis, it could be feared that patients with AF would refrain from consulting their health-care provider resulting in suboptimal care potentially reflected by an increase in the proportion of thromboembolic complications related to AF.

Using Danish nationwide administrative registries, we examined patients with a hospital contact due to incident TE following the COVID-19 lockdown in Denmark (effectuated on the 12 March 2020) as well as the corresponding period in 2019. Data regarding the diseases of interest were obtained from diagnostic codes in the Danish National Patient Registry, which contains information on all hospital contacts in Denmark as described in more detail elswhere. 3, 4 We included all patients above 18 years of age with a hospital contact registered with a primary diagnosis of either ischemic stroke, transient ischemic attack or systemic embolism. Of interest, we analyzed the proportion of AF-related TEs to the total amount of TEs in the period. AF was defined as a registered diagnosis of AF prior to or in relation with hospitalization due to TE. March) as well as the preceding weeks in both 2020 and 2019. (Figure 1 B) The perspective of patients with acute or subacute conditions requiring medical attention refraining from seeking physician treatment due to COVID-19 is worrisome and warrants further investigations especially regarding the potential associated effects on patient outcomes. 5 It could be speculated that perceptions regarding symptom severity have been affected in the COVID-19 situation due to a desire to avoid healthcare providers out of fear of becoming infected or disturbing caregivers, especially in case of perceived mild symptoms.

Reassuringly, in a Danish context, we could not find indications that the proportion of AF-related TEs has increased as a result of inadequate anticoagulation strategies during the lockdown period as could be feared. However, it is unknown whether a delayed effect of the lockdown will be observed later on and the development in registered diseases should be closely monitored.

Consequently, contemporary Danish data do not point toward an excess of thromboembolic complications associated with AF during the COVID-19 lockdown suggesting timely treatment and visitation of AF patients. In this context, it is worth noting the major role telemedicine has played in the outpatient clinics during the lockdown and it could be speculated whether this has resulted in adequate care and could potentially continue to do so in the future. There is no funding to declare for this study. 

New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people

Collateral Effect of Covid-19 on Stroke Evaluation in the United States

Gastrointestinal bleeding and the risk of colorectal cancer in anticoagulated patients with atrial fibrillation

The Danish National Patient Registry: a review of content, data quality, and research potential